skinfix-triple-lipid-peptide-face-cream Recombinant human brain natriuretic peptide (rhBNP) is a synthetic peptide that mimics the action of naturally occurring brain natriuretic peptide (BNP). Primarily produced by the heart's ventricles in response to increased cardiac stretch, BNP plays a crucial role in cardiovascular homeostasis. Its functions include promoting natriuresis (sodium excretion), diuresis (water excretion), vasodilation, and inhibiting the renin-angiotensin-aldosterone system. These actions collectively help to reduce blood pressure and alleviate the workload on the heart. The development of recombinant human brain natriuretic peptide has opened new avenues for treating various cardiovascular ailments, particularly heart failureSynthetic recombinant human BNP (rh-BNP) plays a role in inducing vasodilation, particularly in the venous system, alleviating cardiac congestion, and enhancing ....
Brain natriuretic peptide (BNP) is a vital cardiac hormoneBrain-typeNatriuretic Peptide(BNP) is a nonglycosylated peptide that is produced predominantly byventricular myocytes and belongs to the natriuretic peptide .... When the heart muscle is overstretched, such as in heart failure, it releases BNP. This release triggers a cascade of physiological responses designed to reduce the heart's burden. BNP helps the body get rid of excess salt and water, relaxes blood vessels, and counteracts hormones that raise blood pressure. These combined effects lead to a decrease in blood volume and pressure, easing the strain on a failing heart.
Recombinant human brain natriuretic peptide (rhBNP) is engineered to replicate these beneficial effects. By administering a synthetic version of BNP, clinicians can directly augment the body's natural mechanisms for managing cardiovascular stress.Clinical study of recombinant human brain natriuretic ... This therapeutic approach is particularly relevant for patients suffering from acute decompensated heart failure (ADHF), where rapid intervention is critical to stabilize the patient and improve cardiac function作者：L Liang·2020·被引用次数：6—Recombinant human brain natriuretic peptide (rhBNP)is effective in the treatment of acute or chronic heart failure. In addition, an animal ....
The primary application for recombinant human brain natriuretic peptide lies in the management of heart failure. Studies and clinical trials have demonstrated its efficacy in improving cardiac function and hemodynamics in patients with both acute and chronic heart failure.Recombinant human brain natriuretic peptide ameliorates ... RhBNP has been shown to:
* Improve Cardiac Function: By reducing afterload and preload, rhBNP helps the heart pump more efficientlyHuman Brain Natriuretic Peptide/NT-proBNP Protein. This can lead to improved ejection fraction and overall cardiac output.Impact of recombinant human brain natriuretic peptide on ...
* Reduce Congestion: Its diuretic and natriuretic properties help to clear excess fluid from the body, alleviating symptoms like shortness of breath and edema associated with fluid overload作者：Z Ge·2025·被引用次数：2—Recombinant human brain natriuretic peptide combined with Xinmailongis effective in treating heart failure, significantly improving cardiac function..
* Induce Vasodilation: RhBNP relaxes blood vessels, particularly the venous system, which further reduces the pressure the heart needs to pump against and enhances venous return.
* Mitigate Cardiovascular Events: In certain patient populations, such as those with end-stage renal disease (ESRD) and heart failure, rhBNP has been observed to reduce the occurrence of emergency dialysis and cardiovascular events.
* Possess Antioxidant and Anti-inflammatory Effects: Emerging research suggests that rhBNP may also offer protective benefits through its antioxidant and anti-inflammatory actions, contributing to better cardiovascular health.Recombinant Human BNP-32 Protein
Furthermore, recombinant human brain natriuretic peptide has been explored in the context of post-cardiotomy patients and those with acute myocardial infarction, where its ability to improve cardiac output and venous return function can be critical for recovery.
While rhBNP is a therapeutic agent, B-type natriuretic peptide (BNP) and its precursor, N-terminal pro-brain natriuretic peptide (NT-proBNP), are widely used as diagnostic biomarkers. Elevated levels of BNP or NT-proBNP in the blood are strong indicators of cardiac stress and are commonly used to diagnose and assess the severity of heart failure. Understanding the difference between the therapeutic rhBNP and the diagnostic NT-proBNP is important. Recombinant human NT-proBNP is also available and is used in research and diagnostic contexts, but it is distinct from the rhBNP used for treatment.
Recombinant human brain natriuretic peptide is typically administered intravenously. It is often formulated as a lyophilized powder that is reconstituted before administration.Recombinant Human Natriuretic Peptides Bis produced by our E.coli expression system and the target gene encoding His27-His134 is expressed with a 6His tag ... This formulation ensures stability and allows for precise dosing. The specific formulation and delivery method may vary depending on the clinical indication and the product used.
Recombinant human brain natriuretic peptide is generally considered to have a good safety profile when administered under medical supervision. Adverse effects are usually mild and related to its vasodilatory action, such as hypotension. Ongoing research continues to explore the full therapeutic potential of rhBNP, including its use in combination therapies and for a wider range of cardiovascular conditions. Its ability to directly address the physiological mechanisms underlying heart failure makes it a valuable tool in modern cardiovascular medicine.
Join the newsletter to receive news, updates, new products and freebies in your inbox.